Joshua S. Lev, who serves as both Chief Financial Officer and Interim President of electroCore, Inc., conducted a sale of company stock on May 28, 2026. Specifically, Mr. Lev sold 6,667 shares of the common stock, totaling $60,003 in value.
The weighted average price for these individual sales was determined to be $9.00 per share. The actual transaction prices varied slightly, ranging from $8.95 up to $9.09 per share. This sale comes at a time when electroCore stock is trading close to its 52-week high of $9.68, following an impressive 38.5% gain over the past week.
Following this divestiture, Mr. Lev's direct ownership stake in electroCore common stock stands at 84,889 shares. This total comprises 2,889 currently held common shares and 82,000 common shares that are slated to become issuable through Restricted Stock Units (RSUs). These RSUs are subject to various vesting schedules extending through January 2029.
Recent corporate developments provide a mix of financial data and operational progress for the company. Electrocore LLC reported achieving record-high quarterly revenue during the first quarter of 2026. Net sales reached $9.6 million, marking a significant increase of 43% when compared to the corresponding period in the previous year.
However, the financial report also indicated a GAAP net loss totaling $5.3 million. This figure represents an escalation from the $3.9 million net loss recorded during the first quarter of 2025. Beyond these core financial metrics, Electrocore announced progress regarding its clinical study results. These findings were published in JAMA Network Open.
The specific study detailed the evaluation of a modified Quell device for treating fibromyalgia. This wearable stimulation device is authorized by the FDA and is utilized alongside standard outpatient physical therapy treatment protocols. The research involved 384 participants, who were divided into groups receiving physical therapy either with or without the use of the Quell device. These combined developments underscore recent activities and ongoing progress across different facets of the company's operations.
Analyst sentiment regarding electroCore suggests a positive outlook for profitability in the current year, with net income expected to show growth. Investors seeking deeper analysis are advised to consult resources like InvestingPro for detailed insights, including Fair Value analysis and comprehensive Pro Research Reports.
Risks
- Despite strong revenue growth, the net loss increased year-over-year (from $3.9 million to $5.3 million), indicating ongoing profitability challenges.
- The CFO's sale of shares occurs while the stock is rallying near its 52-week high, which some may interpret as a signal regarding valuation.
More from Insider Trading